ZANUSSO, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 5.649
EU - Europa 4.437
AS - Asia 3.821
SA - Sud America 464
AF - Africa 51
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.464
Nazione #
US - Stati Uniti d'America 5.587
GB - Regno Unito 1.487
SG - Singapore 1.455
CN - Cina 1.411
IT - Italia 514
HK - Hong Kong 449
SE - Svezia 445
BR - Brasile 409
RU - Federazione Russa 391
FR - Francia 386
IE - Irlanda 330
DE - Germania 329
FI - Finlandia 315
VN - Vietnam 137
KR - Corea 115
UA - Ucraina 87
ID - Indonesia 56
CA - Canada 44
IN - India 36
BE - Belgio 31
JP - Giappone 31
AU - Australia 30
AT - Austria 28
IR - Iran 28
TR - Turchia 25
AR - Argentina 20
NL - Olanda 18
ES - Italia 17
ZA - Sudafrica 15
BD - Bangladesh 13
IL - Israele 13
PL - Polonia 13
TG - Togo 10
CZ - Repubblica Ceca 9
EC - Ecuador 8
MX - Messico 8
NO - Norvegia 8
VE - Venezuela 8
CL - Cile 7
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
CO - Colombia 5
IQ - Iraq 5
MA - Marocco 5
PK - Pakistan 5
CH - Svizzera 4
AL - Albania 3
EG - Egitto 3
GT - Guatemala 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HT - Haiti 1
HU - Ungheria 1
KE - Kenya 1
KW - Kuwait 1
MD - Moldavia 1
MG - Madagascar 1
MR - Mauritania 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
Totale 14.459
Città #
Southend 1.333
Chandler 815
Jacksonville 695
Singapore 640
Woodbridge 547
Dallas 496
Hong Kong 448
Dublin 326
Ann Arbor 318
Houston 314
Ashburn 268
Verona 242
Beijing 235
Wilmington 149
Lawrence 139
Princeton 139
Jinan 115
New York 110
Nanjing 109
Shenyang 95
Helsinki 85
The Dalles 81
Hebei 71
Los Angeles 65
Munich 59
Columbus 56
Dong Ket 55
Sindelfingen 52
Jakarta 51
Nanchang 49
Tianjin 48
Buffalo 43
Zhengzhou 42
Ningbo 41
Milan 40
Council Bluffs 36
Changsha 35
Falls Church 35
Boardman 34
Lancaster 34
Redmond 33
Norwalk 32
Brussels 30
Guangzhou 30
Redwood City 30
Fairfield 29
São Paulo 29
Taizhou 29
Haikou 28
Seattle 28
Tokyo 28
Turku 28
Hangzhou 27
Jiaxing 26
Dearborn 25
Fuzhou 25
Nuremberg 25
Chicago 23
Santa Clara 23
Adelaide 22
Lanzhou 22
Redondo Beach 22
Lappeenranta 21
Taiyuan 20
Rio de Janeiro 18
Clearwater 17
Seoul 16
Vienna 16
Toronto 15
Kent 14
Washington 14
Boston 13
Rome 13
Belo Horizonte 12
Moscow 12
San Francisco 12
Brooklyn 11
Düsseldorf 11
Falkenstein 11
Dongguan 10
Hanoi 10
Ho Chi Minh City 10
Lomé 10
Montreal 10
Detroit 9
Johannesburg 9
London 9
Shanghai 9
Frankfurt am Main 8
Stockholm 8
Warsaw 8
Atlanta 7
Buenos Aires 7
Menlo Park 7
Olomouc 7
Ottawa 7
Salvador 7
Ankara 6
Auckland 6
Bologna 6
Totale 9.555
Nome #
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease with the P102L mutation. 191
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 178
Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia. 159
Increased glutaminyl cyclase expression in peripheral blood of Alzheimer's Disease patients. 157
Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples 157
Specific and surrogate cerebrospinal fluid markers in Creutzfeldt–Jakob Disease (chapter 17) 151
A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. 150
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 150
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 149
A test for Creutzfeldt-Jakob disease using nasal brushings. 147
The proteome: anno Domini 2002 143
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 140
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 140
Molecular analysis of iatrogenic scrapie in Italy 137
Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping 136
Immunoaffinity reactors for prion protein qualitative analysis 135
Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease 133
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. 133
Chapter 19 – Prion protein amplification techniques 133
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 130
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 130
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 130
T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy 128
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 128
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 128
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 128
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 127
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 125
Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease 125
Cerebral amyloidoses: molecular pathways and therapeutic challenges 124
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 123
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 123
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 123
Detection and diagnosis of prion diseases using RT-QuIC: an update 123
Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. 121
Neurodegeneration-associated proteins in human olfactory neurons collected by nasal brushing 120
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 119
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 118
Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy 117
Human peripheral nerve macrophages in normal and pathological conditions 117
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 115
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 114
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies 114
HCV-related nervous system disorders. 113
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. 112
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes 111
Chapter 14 – Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker 111
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 111
Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation 110
HIV-associated PML presenting as epilepsia partialis continua 109
Biochemical characterization of prions 109
Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex 108
Detection of CSF 14-3-3 protein in Guillain-Barré syndrome 108
Chapter 5: Inherited prion disease: molecular pathology and cell models. 108
Atypical strains and unpredictable features. 108
Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease 107
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 106
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia 105
Enhanced expression of NGF receptors in multiple sclerosis lesions. 104
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 104
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. 103
Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease 103
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 103
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 103
Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis 103
Rapidly progressive dementia in hypereosinophilic syndrome 100
Simultaneus occurence of spongiform encephalopathy in a man and his cat in Italy 100
The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome 99
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 99
Prion strain characterization of a novel subtype of Creutzfeldt-Jakob disease 99
Myelin uncompaction and axo-glial detachment in chronic ataxic neuropathy with monospecific IgM antibody to ganglioside GD1b 99
Increased serum levels of ICAM-1 ELAM-1 and TNF-a in inflammatory disorders of peripheral nervous system 98
Neuroinvasion of the 263K scrapie strain after intranasal administration occurs through olfactory-unrelated pathways. 98
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. 97
A test for Creutzfeldt-Jakob disease using nasal brushings REPLY 96
Anti-cholinergic derangement of cortical metabolism on 18F-FDG PET in a patient with frontotemporal lobar degeneration dementia: a case of the TREDEM Registry 96
Treatment of inflammatory and paraproteinemic neuropathies 95
Long-term preclinical MRI alterations in sporadic Creutzfeldt-Jakob disease 95
Characterization of amyloid-β deposits in bovine brains 94
Post-polio syndrome: clinical manifestations and cerebrospinal fluid markers 92
Bovine spongiform encephalopathy. (chapter 1) 92
The expression and potential function of cellular prion protein in human lymphocytes 91
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome. 90
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 89
Inactivation of prions and amyloid seeds with hypochlorous acid 88
Prion protein expression in different species: analysis with a panel of new mAbs 87
Relative abundance of apoE and Aβ1–42 associated with abnormal prion protein differs between Creutzfeldt-Jakob Disease subtypes 87
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 87
Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease 86
Molecular pathogenesis of prion diseases (Chapter 5) 85
Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease. 84
Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid 84
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration 84
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 83
Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset 83
Proteosomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein 82
Ring trial of 2nd generation RT‐QuIC diagnostic tests for sporadic CJD 82
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease 81
Molecular mechanisms of human prion diseases 81
Virology of the post-polio syndrome 79
Totale 11.290
Categoria #
all - tutte 56.673
article - articoli 53.348
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.325
Totale 113.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021900 0 0 54 102 127 138 25 74 101 29 137 113
2021/20221.266 110 438 11 142 31 44 19 59 45 53 89 225
2022/20232.321 173 240 230 398 211 560 30 170 196 15 70 28
2023/20241.114 45 101 100 110 126 247 51 72 11 48 146 57
2024/20253.241 165 208 140 528 158 107 132 195 494 221 268 625
2025/20261.650 663 498 489 0 0 0 0 0 0 0 0 0
Totale 14.655